OA11152A - Process for preparing trovafloxacin acid salts - Google Patents

Process for preparing trovafloxacin acid salts Download PDF

Info

Publication number
OA11152A
OA11152A OA9900199A OA9900199A OA11152A OA 11152 A OA11152 A OA 11152A OA 9900199 A OA9900199 A OA 9900199A OA 9900199 A OA9900199 A OA 9900199A OA 11152 A OA11152 A OA 11152A
Authority
OA
OAPI
Prior art keywords
acid
formula
compound
minerai
trovafloxacin
Prior art date
Application number
OA9900199A
Other languages
English (en)
Inventor
Keith Michael Devries
Timothy Norris
Peter Robert Rose
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of OA11152A publication Critical patent/OA11152A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cephalosporin Compounds (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
OA9900199A 1998-09-03 1999-08-31 Process for preparing trovafloxacin acid salts OA11152A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9894498P 1998-09-03 1998-09-03

Publications (1)

Publication Number Publication Date
OA11152A true OA11152A (en) 2003-04-17

Family

ID=22271674

Family Applications (1)

Application Number Title Priority Date Filing Date
OA9900199A OA11152A (en) 1998-09-03 1999-08-31 Process for preparing trovafloxacin acid salts

Country Status (40)

Country Link
US (1) US6359137B1 (no)
EP (1) EP0989119A1 (no)
JP (1) JP3354526B2 (no)
KR (1) KR20000022858A (no)
CN (1) CN1248580A (no)
AP (1) AP1118A (no)
AR (1) AR021475A1 (no)
AU (1) AU761035B2 (no)
BG (1) BG103703A (no)
BR (1) BR9904082A (no)
CA (1) CA2281244C (no)
CO (1) CO5251466A1 (no)
EA (1) EA002340B1 (no)
EE (1) EE04118B1 (no)
GE (1) GEP20022785B (no)
GT (1) GT199900142A (no)
HN (1) HN1999000141A (no)
HR (1) HRP990274A2 (no)
HU (1) HUP9902967A3 (no)
ID (1) ID23718A (no)
IL (1) IL131614A0 (no)
IN (1) IN191583B (no)
IS (1) IS5168A (no)
MA (1) MA24966A1 (no)
MY (1) MY130800A (no)
NO (1) NO994261L (no)
NZ (1) NZ337605A (no)
OA (1) OA11152A (no)
PA (1) PA8481001A1 (no)
PE (1) PE20001026A1 (no)
PL (1) PL335246A1 (no)
SG (1) SG74748A1 (no)
SK (1) SK116599A3 (no)
SV (1) SV1999000144A (no)
TN (1) TNSN99164A1 (no)
TR (1) TR199902138A2 (no)
TW (1) TW520369B (no)
UY (1) UY25686A1 (no)
YU (1) YU43199A (no)
ZA (1) ZA995630B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104892507B (zh) * 2015-05-26 2018-08-28 徐州天意动物药业股份有限公司 水溶性甲磺酸沙拉沙星及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
BR9408490A (pt) * 1994-01-18 1997-08-26 Pfizer Processo e intermediários para a preparação de sais do ácido nafftiridonocarboxílico
DK0789697T3 (da) * 1995-06-06 1998-10-19 Pfizer Krystalform af vandfrit 7-([1alfa, 5alfa, 6alfa,]-6-amino-3-azabicyclo[3.1.0]hex-3-yl)-6-fluor-1-(2,4-difluorphenyl)-1,4-d
JPH0912546A (ja) * 1995-06-23 1997-01-14 Chisso Corp アザビシクロ環化合物および製造方法
JPH0912547A (ja) * 1995-06-23 1997-01-14 Chisso Corp ニューキノロン系化合物中間体の製造方法
KR100343909B1 (ko) * 1995-08-29 2003-04-10 화이자 인코포레이티드 트로바플록사신의쯔비터이온형태
PA8464701A1 (es) * 1998-01-16 2000-09-29 Pfizer Prod Inc Procedimiento e intermedios para preparar naftiridonas
US6184380B1 (en) * 1999-01-25 2001-02-06 Pfizer Inc. Process for preparing naphthyridones and intermediates

Also Published As

Publication number Publication date
EA199900708A2 (ru) 2000-04-24
AR021475A1 (es) 2002-07-24
TR199902138A2 (xx) 2000-04-21
YU43199A (sh) 2002-11-15
PL335246A1 (en) 2000-03-13
AP1118A (en) 2002-11-21
NO994261D0 (no) 1999-09-02
AU761035B2 (en) 2003-05-29
CN1248580A (zh) 2000-03-29
CA2281244A1 (en) 2000-03-03
MY130800A (en) 2007-07-31
TW520369B (en) 2003-02-11
HU9902967D0 (en) 1999-10-28
CO5251466A1 (es) 2003-02-28
MA24966A1 (fr) 2000-04-01
HN1999000141A (es) 2000-06-19
JP3354526B2 (ja) 2002-12-09
UY25686A1 (es) 2000-03-31
PE20001026A1 (es) 2000-10-11
EA002340B1 (ru) 2002-04-25
AU4482699A (en) 2000-03-16
NZ337605A (en) 2001-03-30
EP0989119A1 (en) 2000-03-29
BR9904082A (pt) 2000-09-12
CA2281244C (en) 2003-05-20
IN191583B (no) 2003-12-06
EE04118B1 (et) 2003-08-15
EA199900708A3 (ru) 2000-08-28
SG74748A1 (en) 2000-08-22
ID23718A (id) 2000-05-11
US6359137B1 (en) 2002-03-19
HRP990274A2 (en) 2000-10-31
TNSN99164A1 (fr) 2005-11-10
AP9901667A0 (en) 1999-12-31
JP2000086658A (ja) 2000-03-28
SK116599A3 (en) 2000-05-16
IS5168A (is) 2000-03-04
BG103703A (bg) 2001-08-31
SV1999000144A (es) 2000-09-05
HUP9902967A2 (hu) 2000-05-28
NO994261L (no) 2000-03-06
KR20000022858A (ko) 2000-04-25
EE9900457A (et) 2000-04-17
GEP20022785B (en) 2002-09-25
IL131614A0 (en) 2001-01-28
PA8481001A1 (es) 2000-09-29
HUP9902967A3 (en) 2000-11-28
GT199900142A (es) 2001-02-15
ZA995630B (en) 2001-03-01

Similar Documents

Publication Publication Date Title
AU615666B2 (en) New diazols
KR20050030958A (ko) 신규한 1H-이미다조[4,5-c]퀴놀린-4-시아노 및1H-이미다조[4,5-c]퀴놀린-4-카르복스아미드 중간체를통한 1H-이미다조[4,5-c]퀴놀린-4-아민의 제조 방법
HU219403B (hu) Azabiciklo-csoporttal helyettesített kinolon- és naftiridon-karbonsavak és eljárás ezek előállítására
EP0436653A1 (en) Synthesis of camptothecin and analogs thereof
US5227380A (en) Pharmaceutical compositions and methods employing camptothecins
EP0297858A2 (en) Bridged-diazabicycloalkyl quinolone carboxylic acids and esters
US6184380B1 (en) Process for preparing naphthyridones and intermediates
EP0705262A1 (en) Process for asymmetric total synthesis of camptothecin
US6114531A (en) Process for preparing quinolone and naphthyridone carboxylic acids
OA11152A (en) Process for preparing trovafloxacin acid salts
IL112323A (en) Process and intermediates for the preparation of salts of acid 7 - (1a, 5b, 6a) - (6 - amino - 3 azabicyclo [0.1.3] - hex - 3yl) - 1 - (2, 4 - difluorophenyl) - 6 - fluorine - 4,1 - Dihydro - 4 - Oxo - 1,8 - Naphthiridine - 3 - Carboxylate
EP0812838A1 (en) Pyridonecarboxylic acid derivative substituted by bicyclic amino group, ester thereof, salt thereof, and bicyclic amine as intermediate therefor
MXPA99008100A (en) Procedure for preparing aci additional trovafloxacin salts
EP0930297B1 (en) A process for preparing naphthyridones and intermediates
US20020095043A1 (en) Process for preparing naphthyridones and intermediates
JP2951726B2 (ja) ピリドンカルボン酸誘導体およびその合成中間体
WO1996011194A1 (fr) Derive d'acide pyridonecarboxylique et intermediaire servant a effectuer sa synthese
KR100359151B1 (ko) 2환성 아미노기로 치환된 피리돈카르복실산 유도체, 그의 에스테르 및 그의 염 및 이들의 중간체인 2환성 아민
CZ312199A3 (cs) Způsob přípravy trovafloxacinových kyselinových solí
MXPA99007034A (en) Procedure for preparing acids quinolone and naftiridone carboxili
WO1996001260A1 (fr) Derive d'acide pyridone-carboxylique, l'un de ses esters, l'un de ses sels, et produit intermediaire pour la synthese de ces composes
CZ9902648A3 (cs) Způsob výroby chinolon- a naftyridonkarboxylových kyselin